The mechanism observed in the primary and ER+/PR+ groups involves the inhibition of the preferential utilization of glycolysis in cancer cells, and the restoration of traditional aerobic energy metabolism, which generates metabolic profiles characteristic of healthy cell growth and proliferation. The gene discussed is ESR1; the disease is cancer.